Research on Pei Zhengxue's Formulation Series

3.4 Effects of Pei's Soft Liver and Anti-Flatulence Pill on VEGF Expression in Mouse Tumor Tissue

Chapter 259

### 3.4 Effects of Pei's Soft Liver and Anti-Flatulence Pill on VEGF Expression in Mouse Tumor Tissue

From Research on Pei Zhengxue's Formulation Series · Read time 1 min · Updated March 22, 2026

Keywords方药研究, 实验研究, 配方资产, 转化沟通, 4.1 裴氏软肝消痞丸方药药理概括

Section Index

  1. 3.4 Effects of Pei's Soft Liver and Anti-Flatulence Pill on VEGF Expression in Mouse Tumor Tissue

3.4 Effects of Pei's Soft Liver and Anti-Flatulence Pill on VEGF Expression in Mouse Tumor Tissue

In the model control group, large areas of brown-yellow granules were observed in the cytoplasm, indicating strong positive expression; in all treatment groups, the brown-yellow granules were fewer than in the model control group. The MOD was proportional to the positive expression, and the positive expression of VEGF in tumor tissues of the PRGXP low-, medium-, and high-dose groups as well as the cantharidin group was lower than that of the model group, with all differences being statistically significant (p<0.05). There was no statistically significant difference between the PRGXP low-, medium-, and high-dose groups and the cantharidin group (p>0.05). See Table 3 and Figure 5.

Table 3: Effects of Pei's Soft Liver and Anti-Flatulence Pill on VEGF Expression in H22 Mouse Tumor Tissue (x±S)

GroupNumber of MiceDose (g/kg)VEGF MOD
Model Control Group80.364±0.007
PRGXP low-dose group81.00.298±0.007*
PRGXP medium-dose group82.00.287±0.014*
PRGXP high-dose group84.00.300±0.008*
Cantharidin group80.250.295±0.018*

Note: *p<0.05 compared with the model control group


This chapter is prepared for online research and reading; for external materials, please align with original publications and the review process.